levetiracetam

Baxter Healthcare Corporation🇺🇸 United States

FDA Page

Effective Date: Jun 16, 2023
Approval ID: 3d88adda-9580-44bf-b75c-d615c973c1e1
Products: 3 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use LEVETIRACETAM IN SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information for LEVETIRACETAM IN SODIUM CHLORIDE INJECTION.LEVETIRACETAM IN SODIUM CHLORIDE injection, for intravenous useInitial U.S. Approval: 1999

Quick Stats

Total Products3

Labelers2

Label Sections21

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.